The list divides substances into five schedules with Schedule V being the highest risk. Schedule IV means providers must store the drugs securely and keep detailed records of who accesses the drugs and who disposes of it.
The committee said it approved the scheduling because of Propofol’s “potential for misuse” while acknowledging it has an appropriate medical use for sedation.
The new classification begins Aug. 27.
More Articles on Anesthesia:
New Anesthesia Drugs Developed to Be ‘Fast, Clean and Soft’
Anesthesia Medical Group Venture Raises $42M
Drug Shortages May Threaten Surgery Center Openings
